Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
Dr Ruben A. Mesa discusses the design and results of the phase 3 PERSIST- trial of pacritinib for patients with myelofibrosis.